Similar articles for PMID: 25861418

Year	Number of Results
1996	1
1997	1
1998	2
1999	1
2000	1
2002	3
2003	1
2004	1
2005	3
2006	4
2007	5
2008	5
2009	2
2010	5
2011	3
2012	5
2013	9
2014	13
2015	9
2016	10
2017	13
2018	8
2019	5
2020	2
2021	4
2022	4

1

Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice.

Cao Z, Chen X, Lan L, Zhang Z, Du J, Liao L. Cao Z, et al. Nutr Res Pract. 2015 Apr;9(2):129-36. doi: 10.4162/nrp.2015.9.2.129. Epub 2014 Dec 26. Nutr Res Pract. 2015. PMID: 25861418 Free PMC article.

2

Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis.

Guo B, Xie N, Wang Y. Guo B, et al. Bull Cancer. 2015 Mar;102(3):204-12. doi: 10.1016/j.bulcan.2014.09.003. Epub 2015 Mar 4. Bull Cancer. 2015. PMID: 25747889

3

Enhancement of antitumor activity of low-dose 5-fluorouracil by combination with Fuzheng-Yiliu granules in hepatoma 22 tumor-bearing mice.

Cao Z, Liao L, Chen X, Lan L, Hu H, Liu Z, Chen L, Huang S, Du J. Cao Z, et al. Integr Cancer Ther. 2013 Mar;12(2):174-81. doi: 10.1177/1534735412450514. Epub 2012 Jul 12. Integr Cancer Ther. 2013. PMID: 22791308 Free article.

4

Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.

Chen X, Cao Z, Zhang Y, Li J, Wang S, Du J, Liao L. Chen X, et al. Integr Cancer Ther. 2017 Sep;16(3):329-338. doi: 10.1177/1534735416654761. Epub 2016 Jun 22. Integr Cancer Ther. 2017. PMID: 27335087 Free PMC article.

5

Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing mice.

Cao Z, Zhang Z, Huang Z, Wang R, Yang A, Liao L, DU J. Cao Z, et al. Oncol Lett. 2014 Apr;7(4):1260-1264. doi: 10.3892/ol.2014.1856. Epub 2014 Feb 6. Oncol Lett. 2014. PMID: 24660037 Free PMC article.

6

[Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice].

Dai ZJ, Wang XJ, Ji ZZ, Li ZF, Tang W, Kang HF, Ma XB, Liu L. Dai ZJ, et al. Zhong Xi Yi Jie He Xue Bao. 2008 Jul;6(7):720-4. doi: 10.3736/jcim20080712. Zhong Xi Yi Jie He Xue Bao. 2008. PMID: 18601855 Chinese.

7

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270

8

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784

9

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Gao Y, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. doi: 10.1007/s00262-005-0111-9. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362410

10

[Anti-tumor and immune-modulating effect of Jiawei Sijunzi decoction in mice bearing hepatoma H22 tumor].

Chen L, Jin T, Ning C, Wang S, Wang L, Lin J. Chen L, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2019 Feb 28;39(2):241-248. doi: 10.12122/j.issn.1673-4254.2019.02.18. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 30890515 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed